Annual Cash & Cash Equivalents
$28.04 M
-$15.03 M-34.90%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual cash & cash equivalents is $28.04 million, with the most recent change of -$15.03 million (-34.90%) on December 31, 2023.
- During the last 3 years, ZNTL annual cash & cash equivalents has fallen by -$26.91 million (-48.98%).
- ZNTL annual cash & cash equivalents is now -58.31% below its all-time high of $67.25 million, reached on December 31, 2019.
Performance
ZNTL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$41.32 M
+$4.34 M+11.75%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly cash and cash equivalents is $41.32 million, with the most recent change of +$4.34 million (+11.75%) on September 30, 2024.
- Over the past year, ZNTL quarterly cash and cash equivalents has dropped by -$69.43 million (-62.69%).
- ZNTL quarterly cash and cash equivalents is now -84.50% below its all-time high of $266.56 million, reached on June 30, 2023.
Performance
ZNTL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ZNTL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.9% | -62.7% |
| 3 y3 years | -49.0% | -62.7% |
| 5 y5 years | +11.5% | -62.7% |
ZNTL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.0% | at low | -84.5% | +47.4% |
| 5 y | 5-year | -58.3% | at low | -84.5% | +47.4% |
| alltime | all time | -58.3% | +11.5% | -84.5% | +47.4% |
Zentalis Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $41.32 M(+11.7%) |
| Jun 2024 | - | $36.98 M(-1.7%) |
| Mar 2024 | - | $37.62 M(+34.2%) |
| Dec 2023 | $28.04 M(-34.9%) | $28.04 M(-74.7%) |
| Sep 2023 | - | $110.75 M(-58.5%) |
| Jun 2023 | - | $266.56 M(+634.7%) |
| Mar 2023 | - | $36.28 M(-15.8%) |
| Dec 2022 | $43.07 M | $43.07 M(+1.2%) |
| Sep 2022 | - | $42.55 M(-22.8%) |
| Jun 2022 | - | $55.14 M(+80.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $30.57 M(-48.8%) |
| Dec 2021 | $59.71 M(+8.7%) | $59.71 M(+46.3%) |
| Sep 2021 | - | $40.81 M(-17.0%) |
| Jun 2021 | - | $49.17 M(+69.6%) |
| Mar 2021 | - | $29.00 M(-47.2%) |
| Dec 2020 | $54.95 M(-18.3%) | $54.95 M(-40.6%) |
| Sep 2020 | - | $92.55 M(-3.6%) |
| Jun 2020 | - | $96.02 M(+50.8%) |
| Mar 2020 | - | $63.65 M(-5.3%) |
| Dec 2019 | $67.25 M(+167.3%) | $67.25 M |
| Dec 2018 | $25.15 M | - |
FAQ
- What is Zentalis Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Zentalis Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Zentalis Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ZNTL is $28.04 M
What is the all time high annual cash & cash equivalents for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual cash & cash equivalents is $67.25 M
What is Zentalis Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ZNTL annual cash & cash equivalents has changed by -$15.03 M (-34.90%)
What is Zentalis Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ZNTL is $41.32 M
What is the all time high quarterly cash and cash equivalents for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly cash and cash equivalents is $266.56 M
What is Zentalis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ZNTL quarterly cash and cash equivalents has changed by -$69.43 M (-62.69%)